Xcout Intel
Good Therapeutics, Inc.
Good Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington. The firm focuses on drug discovery and the development of novel therapeutic pipelines and biopharmaceuticals.
Subscribe to see Good Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Good Therapeutics, Inc. at a glance
Good Therapeutics, Inc. is a biopharma company headquartered in United States. Its most recent funding round raised $8.8M in December 2021. Xcout tracks 14 named people at Good Therapeutics, Inc., including John Mulligan (Chief Executive Officer).
Good Therapeutics, Inc. leadership
- John MulliganChief Executive Officer
- Diane HollenbaughChief Scientific Officer
- Neela PatelChief Business Officer
- Karl HandelsmanFounder & Managing Partner, Codon Capital
- Cindy YeeVice President, Corporate Strategy & Operations
- Justin Killebrew, PhDVice President of Biology
8 more named people on record for Good Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Good Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $8.8M | — | |
| Series B | $10M | 4 named | |
| SEC Form D filing | $11.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Good Therapeutics, Inc. competitors
A few of Good Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Bonum Therapeutics, Inc. is a startup holding company operating in the therapeutics and drug pipeline sector in Washington, United States.
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Bridge Medicines LLC is a drug discovery holding company headquartered in New York, NY, that accelerates the path of therapeutic pipelines from research to patients.
Alpine Immune Sciences, Inc. is a publicly traded clinical-stage biopharmaceutical company founded in 2015. Headquartered in Seattle, Washington, the company focuses on discovering and developing innovative immunotherapies.
Goldenrod Therapeutics, Inc. is a biotechnology innovator based in Houston, Texas, developing treatments for brain inflammation and PDE4B inhibitors for neurological conditions and substance use disorder.
Tortugas Neuroscience is a drug discovery and biopharmaceutical company headquartered in Framingham, Massachusetts. The company focuses on advancing innovative neuroscience therapeutics.
Get Good Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Good Therapeutics, Inc. in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access